ArticleScientific reports2026
An integrative in silico and in vitro synergy of Cinnamomum verum essential oil and cinnamaldehyde with imipenem against extensively drug-resistant Gram-negative bacteria.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
Acinetobacter baumannii and Klebsiella pneumoniae bacterial pathogens are associated with multidrug-resistant hospital-acquired infections. This study aimed to assess the phytochemical composition, antibacterial efficacy, synergistic interactions, molecular docking, and molecular dynamics of the essential oil Cinnamomum verum (Civ-EO) and its major compound. Cinnamaldehyde was identified as the major component of Civ-EO (70.15%). Disc diffusion and MBC/MIC showed advanced antibacterial activity of Civ-EO against extensively drug-resistant (XDR) strains of Acinetobacter baumannii and Klebsiella pneumoniae. Synergism between Cinn-EO and imipenem was revealed by combined disc diffusion and confirmed by checkerboard assays against all XDR Acinetobacter baumannii and Klebsiella pneumoniae isolates (FICI˂0.5). Cinnamaldehyde displayed important antibacterial effects alone and in combination with imipenem (FICI˂0.5) against all used XDR and susceptible strains. Molecular docking demonstrated the highest interaction between cinnamaldehyde and undecaprenyl pyrophosphate synthase enzymes and D-alanine: D-alanine ligase. According to molecular dynamics simulations, the stabilizing effects of ligand binding on the target enzyme reduce its activity. The current study demonstrates the highly antibacterial effects of cinnamaldehyde in combination with imipenem against XDR Acinetobacter baumannii and Klebsiella pneumoniae, which could constitute an interesting strategy for combating these bacteria.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.